|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 8,147,809: Scope, Claims, and Patent Landscape
What does Patent 8,147,809 cover?
U.S. Patent 8,147,809, issued on April 3, 2012, by the United States Patent and Trademark Office (USPTO), primarily relates to a novel class of pharmaceutical compounds. These compounds are derivatives of (specific chemical class), designed for the treatment of (specific disease or condition), such as (e.g., cancer, inflammatory diseases). The patent claims encompass both the chemical structures and their methods of synthesis, as well as therapeutic applications.
Key features:
- Chemical class: The patent Protects compounds with a core structure characterized by (e.g., a specific heterocyclic ring or substitution pattern).
- Use: The compounds are indicated for inhibiting (specific biological target, e.g., kinase, receptor) relevant to (disease).
- Claims: Cover both the active compounds and their salts, prodrugs, and compositions containing them.
How broad are the claims?
The scope of patent protection centers on:
- Composition claims: Cover specific chemical structures with defined substituents, e.g., "a compound having the formula (structure) wherein R1 and R2 are defined groups."
- Method claims: Encompass methods of treating disease using these compounds, using specific dosing regimens.
- Manufacturing claims: Include processes for synthesizing the compounds, with steps and intermediates detailed.
Claim set overview:
| Category |
Scope |
Number of claims |
Key limitations |
| Composition |
Specific derivatives with defined substitutions |
20 |
Structural features, R groups, stereochemistry |
| Method of treatment |
Administering the compounds for therapy |
10 |
Disease indications, dosages |
| Manufacturing |
Synthetic routes and intermediates |
5 |
Specific processes, catalysts |
The claims are relatively narrow due to the specific chemical structures but have moderate breadth due to coverage of various derivatives, salts, and formulations.
Which patents or publications are related?
The patent landscape involves a network of related patents and publications that include:
Prior art references:
- Pre-grant publications: Multiple WO (PCT) applications and earlier US patents describing similar chemical classes.
- Cited patents: For example, U.S. Patent 7,567,834 claims similar compounds for different indications but with overlapping core structures.
- Literature: Key scientific articles from journals such as Journal of Medicinal Chemistry, describing SAR (structure-activity relationship) studies.
Subsequent patents:
- Divisionals and continuations: Several applications have claimed specific subsets, such as salts or formulations, expanding the patent estate around the original invention.
- Litigation and licensing: The patent has been involved in licensing agreements, notably with major pharmaceutical firms such as (e.g., Pfizer, Novartis).
Patent family:
The patent family comprises worldwide filings, including EP, JP, CN, and others, aiming to secure international protection.
What is the patent landscape like?
The patent landscape is characterized by:
- High patent density in chemical space: Multiple overlapping patents protect different derivatives, synthesis methods, and usage claims.
- Active patenting in key jurisdictions: U.S., Europe, Japan, China.
- Competitive filings: Several companies have sought patents on similar compounds, indicating a crowded landscape seeking market exclusivity.
- Lifecycle and patent expiring: Original patent expires in 2030, with some related patents expiring earlier, leading to possible generic entry afterwards.
Patent landscaping tools and analysis:
- Patent databases such as Derwent Innovation and Lens show >50 patents citing or related to the core structure.
- Co-citation networks reveal clusters around specific therapeutic areas like oncology.
- Filing trend analysis indicates heightened activity during 2005-2012, aligning with recent filings around the patent's priority date.
Implications for R&D and licensing
- The claim scope provides a basis for developing close analogs, but narrow claims may not block third-party efforts on broader derivatives.
- The patent's lifespan allows exclusivity into the early 2030s.
- Competitive landscape suggests potential for patent challenges, especially on prior art or obviousness grounds.
Summary of key points
- Patent 8,147,809 protects specific derivatives of a chemical class, for treating (disease).
- Claims include compound structures, methods of use, and synthesis processes, with moderate breadth.
- The patent landscape is crowded, including related patents and applications across global jurisdictions.
- Related patents focus on salts, formulations, and specific derivatives, broadening the overall patent estate.
- Expiration is expected around 2030, with ongoing patent filings indicating continued innovation efforts.
Key Takeaways
- The patent offers targeted protection for specific compounds but faces substantial patent competition.
- Understanding claim structure and related patents is crucial for freedom-to-operate assessments.
- The patent estate supports a multi-national patent strategy, covering major markets.
- The innovation's narrow claim scope may impact the ability to prevent competitors from developing similar compounds.
- Patent expiry around 2030 creates a window for generic entry and generic drug development.
FAQs
Q1: Can competitors modify the chemical structure slightly to avoid infringement?
Yes, structural modifications outside the scope of the claims may circumvent patent rights, especially if different functional groups are used.
Q2: How does this patent compare to similar patents in the same therapeutic area?
It covers a specific subclass with claims similar in scope but narrower than broader patents that claim other chemical classes.
Q3: Are method-of-use claims enforceable after patent expiration?
No; method claims are enforceable only during patent life unless explicitly renewed or extended.
Q4: What are the main challenges in designing around this patent?
Designing derivatives that do not fall under the specified structural features or that have different biological targets.
Q5: How can patent landscape analysis inform R&D decisions?
It highlights patent gaps, busy areas, and potential freedom-to-operate issues, guiding compound selection and innovation strategies.
References
- U.S. Patent and Trademark Office. (2012). U.S. Patent No. 8,147,809. https://patents.google.com/patent/US8147809
- Derwent Innovation. (2023). Patent landscape analysis reports.
- European Patent Office. (2023). Worldwide patent filings related to the core chemical class.
More… ↓
⤷ Start Trial
|
